• 2025
  Sabec MH, Savage QR, Wood JL, Maskos U, Targeting high-affinity nicotinic receptors protects against the functional consequences of β-amyloid in mouse hippocampus., Mol Psychiatry 2025 Feb; 30(2): 556-566.
• 2025
  Yang D, Qi G, Delev D, Maskos U, Feldmeyer D, Linking altered neuronal and synaptic properties to nicotinic receptor Alpha5 subunit gene dysfunction: a translational investigation in rat mPFC and human cortical layer 6., Transl Psychiatry 2025 Jan; 15(1): 12.
• 2024
  Tochon L, Henkous N, Besson M, Maskos U, David V, Distinct Chrna5 mutations link excessive alcohol use to types I/II vulnerability profiles and IPN GABAergic neurons., Transl Psychiatry 2024 Nov; 14(1): 461.
• 2024
  Boukouaci W, Lajnef M, Wu CL, Bouassida J, Saitoh K, Sugunasabesan S, Richard JR, Apavou M, Lamy A, Henensal A, Nkam I, Hasty L, Sayous R, Bengoufa D, Barau C, Le Corvoisier P, Honnorat J, Maskos U, Yolken R, Leboyer M, Tamouza R, B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia., Brain Behav Immun 2024 Oct; 121(): 178-188.
• 2024
  Görgülü I, Jagannath V, Pons S, Koniuszewski F, Groszer M, Maskos U, Huck S, Scholze P, The human-specific nicotinic receptor subunit CHRFAM7A reduces α7 receptor function in human induced pluripotent stem cells-derived and transgenic mouse neurons., Eur J Neurosci 2024 Sep; 60(5): 4893-4906.
• 2024
  Darrau E, Jacquemet E, Pons S, Schlick L, Zouridakis M, Wu CL, Richard JR, Barau C, Le Corvoisier P, Yolken R, Tamouza R, Leboyer M, Maskos U, Serum autoantibodies against α7-nicotinic receptors in subgroups of patients with bipolar disorder or schizophrenia: clinical features and link with peripheral inflammation., Transl Psychiatry 2024 Mar; 14(1): 146.
• 2023
  Prevost MS, Barilone N, Dejean de la Bâtie G, Pons S, Ayme G, England P, Gielen M, Bontems F, Pehau-Arnaudet G, Maskos U, Lafaye P, Corringer PJ, An original potentiating mechanism revealed by the cryo-EM structures of the human α7 nicotinic receptor in complex with nanobodies., Nat Commun 2023 Sep; 14(1): 5964.
• 2023
  Mondoloni S, Nguyen C, Vicq E, Ciscato M, Jehl J, Durand-de Cuttoli R, Torquet N, Tolu S, Pons S, Maskos U, Marti F, Faure P, Mourot A, Prolonged nicotine exposure reduces aversion to the drug in mice by altering nicotinic transmission in the interpeduncular nucleus., Elife 2023 May; 12(): .
• 2023
  Li Q, Nemecz Á, Aymé G, Dejean de la Bâtie G, Prevost MS, Pons S, Barilone N, Baachaoui R, Maskos U, Lafaye P, Corringer PJ, Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor., Cell Mol Life Sci 2023 May; 80(6): 164.
• 2023
  Llach Pou M, Thiberge C, Van der Zwan M, Devi Govindan A, Pons S, Maskos U, Cloëz-Tayarani I, Developmental Changes of Human Neural Progenitor Cells Grafted into the Ventricular System and Prefrontal Cortex of Mouse Brain in Utero., Cells 2023 Mar; 12(7): .
• 2023
  Lakosa A, Rahimian A, Tomasi F, Marti F, Reynolds LM, Tochon L, David V, Danckaert A, Canonne C, Tahraoui S, de Chaumont F, Forget B, Maskos U, Besson M, Impact of the gut microbiome on nicotine’s motivational effects and glial cells in the ventral tegmental area in male mice., Neuropsychopharmacology 2023 May; 48(6): 963-974.
• 2023
  Raïs C, Gaspar Santos D, Sansone G, Blanchard S, Bourgeois JP, Jagla B, Saudemont B, Schlick L, Pons S, Maskos U, Functional maturation of human iPSC-derived pyramidal neurons in vivo is dependent on proximity with the host tissue., Front Cell Neurosci 2023 ; 17(): 1259712.
• 2023
  Vilella A, Romoli B, Bodria M, Pons S, Maskos U, Zoli M, Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice., Front Neurosci 2023 ; 17(): 1097857.
• 2022
  Dormoy V, Pons S, Gosset P, Maskos U, [Nicotinic acetylcholine receptor and chronic obstructive pulmonary disease]., Med Sci (Paris) 2022 ; 38(8-9): 637-639.
• 2022
  L. Massara, L. Saber Cherif, Stéphanie Pons, G. Kervoaze, A. Ollivier, M. Pichavant, Valérian Dormoy, Uwe Maskos, P. Gosset, Gene environment interaction in COPD: Involvement of a nicotinic receptor gene polymorphism, Journées de Recherche Respiratoire (J2R), Oct 2022, Reims, France. 40 (2), pp.115, 2023, ⟨10.1016/j.rmr.2022.11.014⟩.
• 2022
  Camille Thiberge, Maria Llach Pou, Aline Vitrac, Uwe Maskos, Isabelle Cloëz-Tayarani, Humanized Chimeric Mouse Models to Study Human Neural Development and Pathogenesis of Brain Diseases, Translational Research Methods in Neurodevelopmental Disorders, 185, Springer US, pp.135-158, 2022, Neuromethods, 978-1-0716-2569-9. ⟨10.1007/978-1-0716-2569-9_8⟩.
• 2022
  Saber Cherif L, Diabasana Z, Perotin JM, Ancel J, Petit LMG, Devilliers MA, Bonnomet A, Lalun N, Delepine G, Maskos U, Gosset P, Polette M, Muggeo A, Guillard T, Deslée G, Dormoy V, The Nicotinic Receptor Polymorphism rs16969968 Is Associated with Airway Remodeling and Inflammatory Dysregulation in COPD Patients., Cells 2022 Sep; 11(19): .
• 2022
  Breum AW, Falk S, Svendsen CSA, Nicolaisen TS, Mathiesen CV, Maskos U, Clemmensen C, Divergent Roles of α5 and β4 Nicotinic Receptor Subunits in Food Reward and Nicotine-induced Weight Loss in Male Mice., Endocrinology 2022 Jul; 163(7): .
• 2022
  Dormoy V, Perotin JM, Gosset P, Maskos U, Polette M, Deslée G, Nicotinic receptors as SARS-CoV-2 spike co-receptors?, Med Hypotheses 2022 Jan; 158(): 110741.
• 2021
  Rajah MM, Hubert M, Bishop E, Saunders N, Robinot R, Grzelak L, Planas D, Dufloo J, Gellenoncourt S, Bongers A, Zivaljic M, Planchais C, Guivel-Benhassine F, Porrot F, Mouquet H, Chakrabarti LA, Buchrieser J, Schwartz O, , SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation., EMBO J 2021 12; 40(24): e108944.
• 2021
  Zhang CL, Koukouli F, Allegra M, Ortiz C, Kao HL, Maskos U, Changeux JP, Schmidt-Hieber C, Inhibitory control of synaptic signals preceding locomotion in mouse frontal cortex., Cell Rep 2021 Nov; 37(8): 110035.
• 2021
  Routhier J, Pons S, Freidja ML, Dalstein V, Cutrona J, Jonquet A, Lalun N, Mérol JC, Lathrop M, Stitzel JA, Kervoaze G, Pichavant M, Gosset P, Tournier JM, Birembaut P, Dormoy V, Maskos U, An innate contribution of human nicotinic receptor polymorphisms to COPD-like lesions., Nat Commun 2021 Nov; 12(1): 6384.
• 2021
  Reger de Moura C, Landras A, Khayati F, Maskos U, Maouche K, Battistella M, Menashi S, Lebbé C, Mourah S, , CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1., Cancers (Basel) 2021 Sep; 13(19): .
• 2021
  Nguyen C, Mondoloni S, Le Borgne T, Centeno I, Come M, Jehl J, Solié C, Reynolds LM, Durand-de Cuttoli R, Tolu S, Valverde S, Didienne S, Hannesse B, Fiancette JF, Pons S, Maskos U, Deroche-Gamonet V, Dalkara D, Hardelin JP, Mourot A, Marti F, Faure P, , Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety., Neuron 2021 08; 109(16): 2604-2615.e9.
• 2021
  Diabasana Z, Perotin JM, Belgacemi R, Ancel J, Mulette P, Launois C, Delepine G, Dubernard X, Mérol JC, Ruaux C, Gosset P, Maskos U, Polette M, Deslée G, Dormoy V, , Chr15q25 Genetic Variant rs16969968 Alters Cell Differentiation in Respiratory Epithelia., Int J Mol Sci 2021 Jun; 22(13): .
• 2021
  Forget B, Icick R, Robert J, Correia C, Prevost MS, Gielen M, Corringer PJ, Bellivier F, Vorspan F, Besson M*, Maskos U* , Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients., Prog Neurobiol 2021 02; 197(): 101898.
• 2021
  Rooy M, Lazarevich I, Koukouli F, Maskos U, Gutkin B, Cholinergic modulation of hierarchical inhibitory control over cortical resting state dynamics: Local circuit modeling of schizophrenia-related hypofrontality., Curr Res Neurobiol 2021 ; 2(): 100018.
• 2020
  Courties A, Do A, Leite S, Legris M, Sudre L, Pigenet A, Petit J, Nourissat G, Cambon-Binder A, Maskos U, Berenbaum F, Sellam J, , The Role of the Non-neuronal Cholinergic System in Inflammation and Degradation Processes in Osteoarthritis., Arthritis Rheumatol 2020 12; 72(12): 2072-2082.
• 2020
  Icick R, Forget B, Cloëz-Tayarani I, Pons S, Maskos U, Besson M, , Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution., Neuropharmacology 2020 10; 177(): 108234.
• 2020
  Diabasana Z, Perotin JM, Belgacemi R, Ancel J, Mulette P, Delepine G, Gosset P, Maskos U, Polette M, Deslée G, Dormoy V, , Nicotinic Receptor Subunits Atlas in the Adult Human Lung., Int J Mol Sci 2020 Oct; 21(20): .
• 2020
  Zorrilla de San Martin J, Donato C, Peixoto J, Aguirre A, Choudhary V, De Stasi AM, Lourenço J, Potier MC, Bacci A, , Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome., Elife 2020 Aug; 9(): .
• 2020
  Vitrac A, Pons S, Balkota M, Lemière N, Raïs C, Bourgeois JP, Maskos U, Bourgeron T, Cloëz-Tayarani I, , A chimeric mouse model to study human iPSC-derived neurons: the case of a truncating SHANK3 mutation., Sci Rep 2020 08; 10(1): 13315.
• 2020
  Maskos U, , The nicotinic receptor alpha5 coding polymorphism rs16969968 as a major target in disease: Functional dissection and remaining challenges., J Neurochem 2020 08; 154(3): 241-250.
• 2020
  Gausserès B, Liu J, Foppen E, Tourrel-Cuzin C, Rodriguez Sanchez-Archidona A, Delangre E, Cruciani-Guglielmacci C, Pons S, Maskos U, Thorens B, Magnan C, Movassat J, Maouche K, , The Constitutive Lack of α7 Nicotinic Receptor Leads to Metabolic Disorders in Mouse., Biomolecules 2020 07; 10(7): .
• 2020
  D'Alessio R, Koukouli F, Blanchard S, Catteau J, Raïs C, Lemonnier T, Féraud O, Bennaceur-Griscelli A, Groszer M, Maskos U, , Long-term development of human iPSC-derived pyramidal neurons quantified after transplantation into the neonatal mouse cortex., Dev Biol 2020 05; 461(1): 86-95.
• 2020
  Husson M, Harrington L, Tochon L, Cho Y, Ibañez-Tallon I, Maskos U, David V, , β4-Nicotinic Receptors Are Critically Involved in Reward-Related Behaviors and Self-Regulation of Nicotine Reinforcement., J Neurosci 2020 04; 40(17): 3465-3477.
• 2020
  Guéniot L, Lepere V, De Medeiros GF, Danckaert A, Flamant P, Le Dudal M, Langeron O, Goossens PL, Chrétien F, Jouvion G, , Muscle Injury Induces Postoperative Cognitive Dysfunction., 2020 02; 10(1): 2768.
• 2019
  Grieder TE1, Besson M, Maal-Bared G, Pons S, Maskos U, van der Kooy D., β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward., Proc Natl Acad Sci U S A. 2019 17;116(51):25968-25973. doi: 10.1073/pnas.1908724116.
• 2019
  Zhang XM, François U, Silm K, Angelo MF, Fernandez-Busch MV, Maged M, Martin C, Bernard V, Cordelières FP, Deshors M, Pons S, Maskos U, Bemelmans AP, Wojcik SM, El Mestikawy S, Humeau Y, Herzog E, , A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency., Elife 2019 Oct; 8(): .
• 2019
  Besson M, Forget B, Correia C, Blanco R, Maskos U, , Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior., Neuropsychopharmacology 2019 10; 44(11): 1906-1916.
• 2019
  Verdonk F, Petit AC, Abdel-Ahad P, Vinckier F, Jouvion G, de Maricourt P, De Medeiros GF, Danckaert A, Van Steenwinckel J, Blatzer M, Maignan A, Langeron O, Sharshar T, Callebert J, Launay JM, Chrétien F, Gaillard R, , Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine., 2019 10; 81(): 361-373.
• 2019
  Vergara-Jaque A, Palma-Cerda F, Lowet AS, de la Cruz Landrau A, Poblete H, Sukharev A, Comer J, Holmgren M, A Structural Model of the Inactivation Gate of Voltage-Activated Potassium Channels., Biophys J 2019 Jul; 117(2): 377-387.
• 2019
  Gouder L, Vitrac A, Goubran-Botros H, Danckaert A, Tinevez JY, André-Leroux G, Atanasova E, Lemière N, Biton A, Leblond CS, Poulet A, Boland A, Deleuze JF, Benchoua A, Delorme R, Bourgeron T, Cloëz-Tayarani I, , Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations., Sci Rep 2019 01; 9(1): 94.
• 2019
  de Medeiros GF, Lafenêtre P, Janthakhin Y, Cerpa JC, Zhang CL, Mehta MM, Mortessagne P, Helbling JC, Ferreira G, Moisan MP, , Corticosteroid-Binding Globulin Deficiency Specifically Impairs Contextual and Recognition Memory Consolidation in Male Mice., 2019 ; 109(4): 322-332.
• 2019
  Gréa H, Bouchet D, Rogemond V, Hamdani N, Le Guen E, Tamouza R, Darrau E, Passerieux C, Honnorat J, Leboyer M, Groc L, , Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics., Front Psychiatry 2019 ; 10(): 670.
• 2018
  Esmaeilzade B, Artimani T, Amiri I, Najafi R, Shahidi S, Sabec M, Farzadinia P, Zare M, Zahiri M, Soleimani Asl S, Dimethyloxalylglycine preconditioning enhances protective effects of bone marrow-derived mesenchymal stem cells in Aβ- induced Alzheimer disease, Physiol. Behav. 2019 02;199:265-272.
• 2018
  Forget B, Scholze P, Langa F, Morel C, Pons S, Mondoloni S, Besson M, Durand-de Cuttoli R, Hay A, Tricoire L, Lambolez B, Mourot A, Faure P, Maskos U, , A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats., Curr Biol 2018 Oct; 28(20): 3244-3253.e7.
• 2018
  Durand-de Cuttoli R, Mondoloni S, Marti F, Lemoine D, Nguyen C, Naudé J, d'Izarny-Gargas T, Pons S, Maskos U, Trauner D, Kramer RH, Faure P, Mourot A, , Manipulating midbrain dopamine neurons and reward-related behaviors with light-controllable nicotinic acetylcholine receptors., Elife 2018 09; 7(): .
• 2018
  Umemori J, Winkel F, Didio G, Llach Pou M, Castrén E, , iPlasticity: Induced juvenile-like plasticity in the adult brain as a mechanism of antidepressants., Psychiatry Clin. Neurosci. 2018 Sep; 72(9): 633-653.
• 2018
  Vitrac A, Cloëz-Tayarani I, Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders, Stem Cell Res Ther 2018 Aug;9(1):226.
• 2018
  Icick R, Vorspan F, Karsinti E, Ksouda K, Lépine JP, Brousse G, Mouly S, Bellivier F, Bloch V, Gender-specific study of recurrent suicide attempts in outpatients with multiple substance use disorders, J Affect Disord 2018 12;241:546-553.
• 2018
  Morel C, Fernandez SP, Pantouli F, Meye FJ, Marti F, Tolu S, Parnaudeau S, Marie H, Tronche F, Maskos U, Moretti M, Gotti C, Han MH, Bailey A, Mameli M, Barik J, Faure P, , Nicotinic receptors mediate stress-nicotine detrimental interplay via dopamine cells’ activity., Mol. Psychiatry 2018 07; 23(7): 1597-1605.
• 2018
  Karsinti E, Piani K, Zerdazi EH, Maskos U, Faure P, Romo L, Bellivier F, Brousse G, Lépine JP, Bloch V, Vorspan F, , Relevance of treated cocaine users’ retrospective memory of first cocaine use., Psychiatry Res 2018 06; 264(): 210-216.
• 2018
  Uspenska K, Lykhmus O, Arias HR, Pons S, Maskos U, Komisarenko S, Skok M, , Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria., Int J Biochem Cell Biol 2018 06; 99(): 226-235.
• 2018
  Sabec MH, Wonnacott S, Warburton EC, Bashir ZI, Nicotinic Acetylcholine Receptors Control Encoding and Retrieval of Associative Recognition Memory through Plasticity in the Medial Prefrontal Cortex, Cell Rep 2018 Mar;22(13):3409-3415.
• 2018
  Benamer N, Marti F, Lujan R, Hepp R, Aubier TG, Dupin AAM, Frébourg G, Pons S, Maskos U, Faure P, Hay YA, Lambolez B, Tricoire L, , GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons., Mol Psychiatry 2018 03; 23(3): 691-700.
• 2018
  Collo G, Cavalleri L, Zoli M, Maskos U, Ratti E, Merlo Pich E, , Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons., Front Pharmacol 2018 ; 9(): 572.
• 2018
  Uspenska K, Lykhmus O, Obolenskaya M, Pons S, Maskos U, Komisarenko S, Skok M, , Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy., Front Pharmacol 2018 ; 9(): 626.
• 2018
  Palma-Cerda F, Papageorgiou G, Barbour B, Auger C, Ogden D, Photolysis of a Caged, Fast-Equilibrating Glutamate Receptor Antagonist, MNI-Caged γ-D-Glutamyl-Glycine, to Investigate Transmitter Dynamics and Receptor Properties at Glutamatergic Synapses., Front Cell Neurosci 2018 ; 12(): 465.
• 2017
  Campagne C, Pons S, Esquerre D, Estellé J, Bourneuf E, Maskos U, Egidy G, , Transcriptome of melanoma cells from two mouse models, Tyr:NRasQ61K and Tyr:Rack1-HA, Tyr:NRasQ61K., Data Brief 2017 Oct; 14(): 32-34.
• 2017
  Icick R, Karsinti E, Lépine JP, Bloch V, Brousse G, Bellivier F, Vorspan F, Serious suicide attempts in outpatients with multiple substance use disorders, Drug Alcohol Depend 2017 Dec;181:63-70.
• 2017
  Campagne C, Reyes-Gomez E, Picco ME, Loiodice S, Salaun P, Ezagal J, Bernex F, Commère PH, Pons S, Esquerre D, Bourneuf E, Estellé J, Maskos U, Lopez-Bergami P, Aubin-Houzelstein G, Panthier JJ, Egidy G, , RACK1 cooperates with NRASQ61K to promote melanoma in vivo., Cell. Signal. 2017 08; 36(): 255-266.
• 2017
  Koukouli F, Rooy M, Tziotis D, Sailor KA, O'Neill HC, Levenga J, Witte M, Nilges M, Changeux JP, Hoeffer CA, Stitzel JA, Gutkin BS, DiGregorio DA, Maskos U, , Nicotine reverses hypofrontality in animal models of addiction and schizophrenia., Nat Med 2017 Mar; 23(3): 347-354.
• 2017
  Deflorio C, Blanchard S, Carisì MC, Bohl D, Maskos U, , Human polymorphisms in nicotinic receptors: a functional analysis in iPS-derived dopaminergic neurons., FASEB J 2017 02; 31(2): 828-839.
• 2017
  Polšek D, Bago M, Živaljić M, Rosenzweig I, Lacza Z, Gajović S, , A novel adjustable automated system for inducing chronic intermittent hypoxia in mice., 2017 ; 12(3): e0174896.
• 2016
  Koukouli F, Rooy M, Changeux JP, Maskos U, , Nicotinic receptors in mouse prefrontal cortex modulate ultraslow fluctuations related to conscious processing., Proc Natl Acad Sci U S A 2016 12; 113(51): 14823-14828.
• 2016
  Koukouli F, Rooy M, Maskos U, Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex, 2016 Dec 20;8(12):3430-3449. .
• 2016
  Koukouli F, Rooy M, Maskos U, , Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex., Aging (Albany NY) 2016 12; 8(12): 3430-3449.
• 2016
  Li T, Vandesquille M, Koukouli F, Dudeffant C, Youssef I, Lenormand P, Ganneau C, Maskos U, Czech C, Grueninger F, Duyckaerts C, Dhenain M, Bay S, Delatour B, Lafaye P, , Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets., J Control Release 2016 Dec; 243(): 1-10.
• 2016
  Biseul I, Icick R, Seguin P, Bellivier F, Scott J, Feasibility and Acceptability of the ‘HABIT’ Group Programme for Comorbid Bipolar and Alcohol and Substance use Disorders, Clin Psychol Psychother 2017 Jul;24(4):887-898.
• 2016
  Lagerberg TV, Aminoff SR, Aas M, Bjella T, Henry C, Leboyer M, Pedersen G, Bellivier F, Icick R, Andreassen OA, Etain B, Melle I, Alcohol use disorders are associated with increased affective lability in bipolar disorder, J Affect Disord 2017 Jan;208:316-324.
• 2016
  Lombardo S, Catteau J, Besson M, Maskos U, , A role for β2* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus., Neurobiol Aging 2016 10; 46(): 221-34.
• 2016
  Icick R, Gard S, Barde M, Carminati M, Desage A, Guillaume S, Scott J, Bellivier F, , Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers, J Affect Disord 2017 Jan;208:406-413.
• 2016
  Besson M, Forget B, Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective, Front Psychiatry 2016;7:160.
• 2016
  Besson M, Guiducci S, Granon S, Guilloux JP, Guiard B, Repérant C, Faure P, Pons S, Cannazza G, Zoli M, Gardier AM, Maskos U, , Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments., Psychopharmacology (Berl) 2016 Sep; 233(18): 3297-314.
• 2016
  de Medeiros GF, Minni AM, Helbling JC, Moisan MP, , Chronic stress does not further exacerbate the abnormal psychoneuroendocrine phenotype of Cbg-deficient male mice., 2016 08; 70(): 33-7.
• 2016
  Karsinti E, Fortias M, Dupuy G, Ksouda K, Laqueille X, Simonpoli AM, Touzeau D, Avril E, Orizet C, Belforte B, Coeuru P, Polomeni P, Icick R, Jarroir M, Bloch V, Scott J, Lépine JP, Bellivier F, Vorspan F, Anxiety disorders are associated with early onset of heroin use and rapid transition to dependence in methadone maintained patients, Psychiatry Res 2016 Nov;245:423-426.
• 2016
  Harrington L, Viñals X, Herrera-Solís A, Flores A, Morel C, Tolu S, Faure P, Maldonado R, Maskos U, Robledo P, , Role of β4* Nicotinic Acetylcholine Receptors in the Habenulo-Interpeduncular Pathway in Nicotine Reinforcement in Mice., Neuropsychopharmacology 2016 Jun; 41(7): 1790-802.
• 2016
  Mercati O, Huguet G, Danckaert A, André-Leroux G, Maruani A, Bellinzoni M, Rolland T, Gouder L, Mathieu A, Buratti J, Amsellem F, Benabou M, Van-Gils J, Beggiato A, Konyukh M, Bourgeois JP, Gazzellone MJ, Yuen RK, Walker S, Delépine M, Boland A, Régnault B, Francois M, Van Den Abbeele T, Mosca-Boidron AL, Faivre L, Shimoda Y, Watanabe K, Bonneau D, Rastam M, Leboyer M, Scherer SW, Gillberg C, Delorme R, Cloëz-Tayarani I, Bourgeron T, CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders, Mol. Psychiatry 2017 04;22(4):625-633.
• 2016
  Belin-Rauscent A, Daniel ML, Puaud M, Jupp B, Sawiak S, Howett D, McKenzie C, Caprioli D, Besson M, Robbins TW, Everitt BJ, Dalley JW, Belin D, Impulsivity is predicted by the thinness of the insular cortex in rats, Mol. Psychiatry 2016 Apr;21(4):445.
• 2016
  Naudé J, Tolu S, Dongelmans M, Torquet N, Valverde S, Rodriguez G, Pons S, Maskos U, Mourot A, Marti F, Faure P, , Nicotinic receptors in the ventral tegmental area promote uncertainty-seeking., Nat Neurosci 2016 Mar; 19(3): 471-8.
• 2016
  Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B, Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats, Psychopharmacology (Berl.) 2016 Feb;.
• 2015
  Lagerberg TV, Icick R, Andreassen OA, Ringen PA, Etain B, Aas M, Henry C, Bjella TD, Melle I, Bellivier F, Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder, J Affect Disord 2016 Jan;190:286-293.
• 2015
  Koukouli F, Maskos U, , The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system., Biochem Pharmacol 2015 Oct; 97(4): 378-387.
• 2015
  Gouder L, Tinevez JY, Goubran-Botros H, Benchoua A, Bourgeron T, Cloëz-Tayarani I, , Three-dimensional Quantification of Dendritic Spines from Pyramidal Neurons Derived from Human Induced Pluripotent Stem Cells., J Vis Exp 2015 Oct; (104): .
• 2015
  Belin-Rauscent A, Daniel ML, Puaud M, Jupp B, Sawiak S, Howett D, McKenzie C, Caprioli D, Besson M, Robbins TW, Everitt BJ, Dalley JW, Belin D, From impulses to maladaptive actions: the insula is a neurobiological gate for the development of compulsive behavior, Mol. Psychiatry 2016 Apr;21(4):491-9.
• 2015
  Changeux JP, Corringer PJ, Maskos U, , The nicotinic acetylcholine receptor: From molecular biology to cognition., Neuropharmacology 2015 Sep; 96(Pt B): 135-6.
• 2015
  Lombardo S, Maskos U, , Role of the nicotinic acetylcholine receptor in Alzheimer’s disease pathology and treatment., Neuropharmacology 2015 Sep; 96(Pt B): 255-62.
• 2015
  Sciaccaluga M, Moriconi C, Martinello K, Catalano M, Bermudez I, Stitzel JA, Maskos U, Fucile S, , Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons., FASEB J 2015 Aug; 29(8): 3389-98.
• 2015
  Milior G, Lecours C, Samson L, Bisht K, Poggini S, Pagani F, Deflorio C, Lauro C, Alboni S, Limatola C, Branchi I, Tremblay ME, Maggi L, Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress, Brain Behav. Immun. 2015 Jul;.
• 2015
  Toli D, Buttigieg D, Blanchard S, Lemonnier T, Lamotte d'Incamps B, Bellouze S, Baillat G, Bohl D, Haase G, Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique, Neurobiol. Dis. 2015 Oct;82:269-80.
• 2015
  Kranz TM, Harroch S, Manor O, Lichtenberg P, Friedlander Y, Seandel M, Harkavy-Friedman J, Walsh-Messinger J, Dolgalev I, Heguy A, Chao MV, Malaspina D, De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample, Schizophr. Res. 2015 Jun;.
• 2015
  Delyon J, Khayati F, Djaafri I, Podgorniak MP, Sadoux A, Setterblad N, Boutalbi Z, Maouche K, Maskos U, Menashi S, Lebbé C, Mourah S, , EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells., Exp Dermatol 2015 Jun; 24(6): 443-8.
• 2015
  Bohl D, Pochet R, Mitrecic D, Nicaise C, Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology, Curr Stem Cell Res Ther 2015 May;.
• 2015
  Wieskopf JS, Mathur J, Limapichat W, Post MR, Al-Qazzaz M, Sorge RE, Martin LJ, Zaykin DV, Smith SB, Freitas K, Austin JS, Dai F, Zhang J, Marcovitz J, Tuttle AH, Slepian PM, Clarke S, Drenan RM, Janes J, Al Sharari S, Segall SK, Aasvang EK, Lai W, Bittner R, Richards CI, Slade GD, Kehlet H, Walker J, Maskos U, Changeux JP, Devor M, Maixner W, Diatchenko L, Belfer I, Dougherty DA, Su AI, Lummis SC, Imad Damaj M, Lester HA, Patapoutian A, Mogil JS, , The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors., Sci Transl Med 2015 May; 7(287): 287ra72.
• 2015
  Fallet V, Saffroy R, Girard N, Mazieres J, Lantuejoul S, Vieira T, Rouquette I, Thivolet-Bejui F, Ung M, Poulot V, Schlick L, Moro-Sibilot D, Antoine M, Cadranel J, Lemoine A, Wislez M, High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets, Ann. Oncol. 2015 Aug;26(8):1748-53.
• 2015
  Medjber K, Freidja ML, Grelet S, Lorenzato M, Maouche K, Nawrocki-Raby B, Birembaut P, Polette M, Tournier JM, Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomas, Lung Cancer 2015 Mar;87(3):258-64.
• 2015
  Khayati F, Pérez-Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak MP, Maskos U, Setterblad N, Janin A, Calvo F, Lebbé C, Menashi S, Fernandez-Recio J, Mourah S, , EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF., Oncotarget 2015 ; 6(12): 9766-80.
• 2015
  Sanjakdar SS, Maldoon PP, Marks MJ, Brunzell DH, Maskos U, McIntosh JM, Bowers MS, Damaj MI, , Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice., Neuropsychopharmacology 2015 Jan; 40(2): 350-60.
• 2014
  Deflorio C, Onesti E, Lauro C, Tartaglia G, Giovannelli A, Limatola C, Inghilleri M, Grassi F, Partial block by riluzole of muscle sodium channels in myotubes from amyotrophic lateral sclerosis patients, Neurol Res Int 2014;2014:946073.
• 2014
  Minni AM, de Medeiros GF, Helbling JC, Duittoz A, Marissal-Arvy N, Foury A, De Smedt-Peyrusse V, Pallet V, Moisan MP, , Role of corticosteroid binding globulin in emotional reactivity sex differences in mice., 2014 Dec; 50(): 252-63.
• 2014
  Bourgonje AM, Navis AC, Schepens JT, Verrijp K, Hovestad L, Hilhorst R, Harroch S, Wesseling P, Leenders WP, Hendriks WJ, Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZ-B differentially regulate glioma cell growth and motility, Oncotarget 2014 Sep;5(18):8690-702.
• 2014
  Bruyère J, Roy E, Ausseil J, Lemonnier T, Teyre G, Bohl D, Etienne-Manneville S, Lortat-Jacob H, Heard JM, Vitry S, Heparan sulfate saccharides modify focal adhesions: implication in mucopolysaccharidosis neuropathophysiology, J. Mol. Biol. 2015 Feb;427(4):775-91.
• 2014
  Dubreuil V, Sap J, Harroch S, Protein tyrosine phosphatase regulation of stem and progenitor cell biology, Semin. Cell Dev. Biol. 2015 Jan;37:82-9.
• 2014
  Moretti M, Zoli M, George AA, Lukas RJ, Pistillo F, Maskos U, Whiteaker P, Gotti C, , The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization., Mol Pharmacol 2014 Sep; 86(3): 306-17.
• 2014
  Muldoon PP, Jackson KJ, Perez E, Harenza JL, Molas S, Rais B, Anwar H, Zaveri NT, Maldonado R, Maskos U, McIntosh JM, Dierssen M, Miles MF, Chen X, De Biasi M, Damaj MI, The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies, Br. J. Pharmacol. 2014 Aug;171(16):3845-57.
• 2014
  Morel C, Fattore L, Pons S, Hay YA, Marti F, Lambolez B, De Biasi M, Lathrop M, Fratta W, Maskos U, Faure P, , Nicotine consumption is regulated by a human polymorphism in dopamine neurons., Mol. Psychiatry 2014 Aug; 19(8): 930-6.
• 2014
  Somm E, Guérardel A, Maouche K, Toulotte A, Veyrat-Durebex C, Rohner-Jeanrenaud F, Maskos U, Hüppi PS, Schwitzgebel VM, , Concomitant alpha7 and beta2 nicotinic AChR subunit deficiency leads to impaired energy homeostasis and increased physical activity in mice., Mol Genet Metab 2014 May; 112(1): 64-72.
• 2014
  Icick R, Peoc'h K, Ksouda K, Bloch V, Laplanche JL, Lépine JP, Bellivier F, Vorspan F, OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients, Psychiatry Res 2014 Aug;218(1-2):259-60.
• 2014
  Icick R, Kovess V, Gasquet I, Lépine JP, [Days out of role due to common mental and physical disorders: French results from the WHO World Mental Health surveys], Encephale 2014 Sep;40(4):338-44.
• 2014
  Icick R, Millet É, Curis E, Bellivier F, Lépine JP, Predictive value of baseline resistance in early response to antidepressants, J Affect Disord 2014 Jun;161:127-35.
• 2014
  Allard J, Li K, Lopez XM, Blanchard S, Barbot P, Rorive S, Decaestecker C, Pochet R, Bohl D, Lepore AC, Salmon I, Nicaise C, Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells, Regen Med 2014;9(4):437-52.
• 2014
  Hervé V, Rabbe N, Guilleminault L, Paul F, Schlick L, Azzopardi N, Duruisseaux M, Fouquenet D, Montharu J, Redini F, Paintaud G, Lemarié E, Cadranel J, Wislez M, Heuzé-Vourc'h N, VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations, MAbs 2014;6(6):1638-48.
• 2013
  Le Foll B, Pushparaj A, Pryslawsky Y, Forget B, Vemuri K, Makriyannis A, Trigo JM, Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach, Prog. Neuropsychopharmacol. Biol. Psychiatry 2014 Jul;52:86-93.
• 2013
  Valley MT, Henderson LG, Inverso SA, Lledo PM, Adult neurogenesis produces neurons with unique GABAergic synapses in the olfactory bulb, J. Neurosci. 2013 Sep;33(37):14660-5.
• 2013
  Icick R, Lauer S, Romo L, Dupuy G, Lépine JP, Vorspan F, Dysfunctional parental styles perceived during childhood in outpatients with substance use disorders, Psychiatry Res 2013 Dec;210(2):522-8.
• 2013
  Deflorio C, Catalano M, Fucile S, Limatola C, Grassi F, Fluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor, Muscle Nerve 2014 Jan;49(1):90-7.
• 2013
  Collo G, Bono F, Cavalleri L, Plebani L, Mitola S, Merlo Pich E, Millan MJ, Zoli M, Maskos U, Spano P, Missale C, , Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling., Mol Pharmacol 2013 Jun; 83(6): 1176-89.
• 2013
  Besson M, Pelloux Y, Dilleen R, Theobald DE, Lyon A, Belin-Rauscent A, Robbins TW, Dalley JW, Everitt BJ, Belin D, Cocaine modulation of frontostriatal expression of Zif268, D2, and 5-HT2c receptors in high and low impulsive rats, Neuropsychopharmacology 2013 Sep;38(10):1963-73.
• 2013
  Wan H, Zhang L, Blanchard S, Bigou S, Bohl D, Wang C, Liu S, Combination of hypoglossal-facial nerve surgical reconstruction and neurotrophin-3 gene therapy for facial palsy, J. Neurosurg. 2013 Sep;119(3):739-50.
• 2013
  Maouche K, Medjber K, Zahm JM, Delavoie F, Terryn C, Coraux C, Pons S, Cloëz-Tayarani I, Maskos U, Birembaut P, Tournier JM, , Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure., Proc Natl Acad Sci U S A 2013 Mar; 110(10): 4099-104.
• 2013
  Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S, Baudonnat M, Husson M, Besson M, Reperant C, Zemdegs J, Pagès C, Hay YA, Lambolez B, Caboche J, Gutkin B, Gardier AM, Changeux JP, Faure P, Maskos U, , Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement., Mol. Psychiatry 2013 Mar; 18(3): 382-93.
• 2013
  Popescu IR, Nicaise C, Liu S, Bisch G, Knippenberg S, Daubie V, Bohl D, Pochet R, Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis, Stem Cells Transl Med 2013 Mar;2(3):167-74.
• 2013
  Mercati O, Danckaert A, André-Leroux G, Bellinzoni M, Gouder L, Watanabe K, Shimoda Y, Grailhe R, De Chaumont F, Bourgeron T, Cloëz-Tayarani I, , Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites., Biol Open 2013 Mar; 2(3): 324-34.
• 2012
  Petit M, Tran C, Roger T, Gallavardin T, Dhimane H, Palma-Cerda F, Blanchard-Desce M, Acher FC, Ogden D, Dalko PI, Substitution effect on the one- and two-photon sensitivity of DMAQ “caging” groups., Org Lett 2012 Dec; 14(24): 6366-9.
• 2012
  Pushparaj A, Pryslawsky Y, Forget B, Yan Y, Le Foll B, Extinction bursts in rats trained to self-administer nicotine or food in 1-h daily sessions, Am J Transl Res 2012;4(4):422-31.
• 2012
  Palma-Cerda F, Auger C, Crawford DJ, Hodgson AC, Reynolds SJ, Cowell JK, Swift KA, Cais O, Vyklicky L, Corrie JE, Ogden D, New caged neurotransmitter analogs selective for glutamate receptor sub-types based on methoxynitroindoline and nitrophenylethoxycarbonyl caging groups., Neuropharmacology 2012 Sep; 63(4): 624-34.
• 2012
  Koukouli F, Paspaltsis I, Salta E, Xanthopoulos K, Koini EN, Calogeropoulou T, Sklaviadis T, Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, Prion 2012 Nov-Dec;6(5):470-6.
• 2012
  Orejarena MJ, Herrera-Solís A, Pons S, Maskos U, Maldonado R, Robledo P, , Selective re-expression of β2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration., Neuropharmacology 2012 Aug; 63(2): 235-41.
• 2012
  Mohebiany AN, Nikolaienko RM, Bouyain S, Harroch S, Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack, FEBS J. 2013 Jan;280(2):388-400.
• 2012
  Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S, Baudonnat M, Husson M, Besson M, Reperant C, Zemdegs J, Pagès C, Hay YA, Lambolez B, Caboche J, Gutkin B, Gardier AM, Changeux JP, Faure P, Maskos U., Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement., Mol Psychiatry. 2013 Mar;18(3):382-93. doi: 10.1038/mp.2012.83..
• 2012
  Bourgeois JP, Meas-Yeadid V, Lesourd AM, Faure P, Pons S, Maskos U, Changeux JP, Olivo-Marin JC, Granon S, , Modulation of the mouse prefrontal cortex activation by neuronal nicotinic receptors during novelty exploration but not by exploration of a familiar environment., Cereb Cortex 2012 May; 22(5): 1007-15.
• 2012
  Deflorio C, Palma E, Conti L, Roseti C, Manteca A, Giacomelli E, Catalano M, Limatola C, Inghilleri M, Grassi F, Riluzole blocks human muscle acetylcholine receptors, J. Physiol. (Lond.) 2012 May;590(10):2519-28.
• 2012
  Rosito M, Deflorio C, Limatola C, Trettel F, CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS, J. Neurosci. 2012 Feb;32(9):3154-63.
• 2012
  Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ, , Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum., J Neurosci 2012 Feb; 32(7): 2352-6.
• 2012
  Chabout J, Serreau P, Ey E, Bellier L, Aubin T, Bourgeron T, Granon S, Adult male mice emit context-specific ultrasonic vocalizations that are modulated by prior isolation or group rearing environment, PLoS ONE 2012;7(1):e29401.
• 2012
  Mitrecic D, Nicaise C, Klimaschewski L, Gajovic S, Bohl D, Pochet R, Genetically modified stem cells for the treatment of neurological diseases, Front Biosci (Elite Ed) 2012;4:1170-81.
• 2011
  Palma E, Inghilleri M, Conti L, Deflorio C, Frasca V, Manteca A, Pichiorri F, Roseti C, Torchia G, Limatola C, Grassi F, Miledi R, Physiological characterization of human muscle acetylcholine receptors from ALS patients, Proc. Natl. Acad. Sci. U.S.A. 2011 Dec;108(50):20184-8.
• 2011
  Nicaise C, Bohl D, Pochet R, [Cellular transdifferentiation in amyotrophic lateral sclerosis], Med Sci (Paris) 2011 Oct;27(10):799-801.
• 2011
  Lamprianou S, Chatzopoulou E, Thomas JL, Bouyain S, Harroch S, A complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the development of oligodendrocyte precursor cells, Proc. Natl. Acad. Sci. U.S.A. 2011 Oct;108(42):17498-503.
• 2011
  Marti F, Arib O, Morel C, Dufresne V, Maskos U, Corringer PJ, de Beaurepaire R, Faure P, , Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice., Neuropsychopharmacology 2011 Oct; 36(11): 2244-57.
• 2011
  Besson M, David V, Baudonnat M, Cazala P, Guilloux JP, Reperant C, Cloez-Tayarani I, Changeux JP, Gardier AM, Granon S, Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice, Psychopharmacology (Berl.) 2012 Mar;220(1):1-14.
• 2011
  Guillem K, Bloem B, Poorthuis RB, Loos M, Smit AB, Maskos U, Spijker S, Mansvelder HD, , Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention., Science 2011 Aug; 333(6044): 888-91.
• 2011
  Toulorge D, Guerreiro S, Hild A, Maskos U, Hirsch EC, Michel PP, , Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+., FASEB J 2011 Aug; 25(8): 2563-73.
• 2011
  Serreau P, Chabout J, Suarez SV, Naudé J, Granon S, Beta2-containing neuronal nicotinic receptors as major actors in the flexible choice between conflicting motivations, Behav. Brain Res. 2011 Nov;225(1):151-9.
• 2011
  Avale ME, Chabout J, Pons S, Serreau P, De Chaumont F, Olivo-Marin JC, Bourgeois JP, Maskos U, Changeux JP, Granon S, , Prefrontal nicotinic receptors control novel social interaction between mice., FASEB J 2011 Jul; 25(7): 2145-55.
• 2011
  Lemonnier T, Blanchard S, Toli D, Roy E, Bigou S, Froissart R, Rouvet I, Vitry S, Heard JM, Bohl D, Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells, Hum. Mol. Genet. 2011 Sep;20(18):3653-66.
• 2011
  Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, Filkin S, Pons S, Fontaine JF, Tsetlin V, Maskos U, Ibañez-Tallon I, , Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula., Neuron 2011 May; 70(3): 522-35.
• 2011
  Exley R, Maubourguet N, David V, Eddine R, Evrard A, Pons S, Marti F, Threlfell S, Cazala P, McIntosh JM, Changeux JP, Maskos U, Cragg SJ, Faure P, , Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine., Proc Natl Acad Sci U S A 2011 May; 108(18): 7577-82.
• 2011
  Piccari V, Deflorio C, Bigi R, Grassi F, Fucile S, Modulation of the Ca(2+) permeability of human endplate acetylcholine receptor-channel, Cell Calcium 2011 Apr;49(4):272-8.
• 2011
  Liu S, Blanchard S, Bigou S, Vitry S, Bohl D, Heard JM, Neurotrophin 3 improves delayed reconstruction of sensory pathways after cervical dorsal root injury, Neurosurgery 2011 Feb;68(2):450-61; discussion 461.
• 2011
  Lykhmus O, Koval L, Skok M, Zouridakis M, Zisimopoulou P, Tzartos S, Tsetlin V, Granon S, Changeux JP, Komisarenko S, Cloëz-Tayarani I, Antibodies against extracellular domains of α4 and α7 subunits alter the levels of nicotinic receptors in the mouse brain and affect memory: possible relevance to Alzheimer’s pathology, J. Alzheimers Dis. 2011;24(4):693-704.
• 2010
  Villégier AS, Salomon L, Granon S, Champtiaux N, Changeux JP, Tassin JP, α7 and β2 nicotinic receptors control monoamine-mediated locomotor response, Neuroreport 2010 Dec;21(17):1085-9.
• 2010
  Azam L, Maskos U, Changeux JP, Dowell CD, Christensen S, De Biasi M, McIntosh JM, , α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release., FASEB J 2010 Dec; 24(12): 5113-23.
• 2010
  Cambon K, Dos-Santos Coura R, Groc L, Carbon A, Weissmann D, Changeux JP, Pujol JF, Granon S, Aggressive behavior during social interaction in mice is controlled by the modulation of tyrosine hydroxylase expression in the prefrontal cortex, Neuroscience 2010 Dec;171(3):840-51.
• 2010
  Maskos U, , Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors., J Neurochem 2010 Aug; 114(3): 641-6.
• 2010
  Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M, , Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors., Biol Psychiatry 2010 Aug; 68(3): 256-64.
• 2010
  Saba W, Valette H, Granon S, Xiao Y, Kellar KJ, Dollé F, Bottlaender M, [18F]ZW-104, a new radioligand for imaging alpha2-alpha3-alpha4/beta2 central nicotinic acetylcholine receptors: Evaluation in mutant mice, Synapse 2010 Jul;64(7):570-2.
• 2010
  Forget B, Wertheim C, Mascia P, Pushparaj A, Goldberg SR, Le Foll B, Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction, Neuropsychopharmacology 2010 Jul;35(8):1751-60.
• 2010
  Forget B, Pushparaj A, Le Foll B, Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction, Biol. Psychiatry 2010 Aug;68(3):265-71.
• 2010
  Tolu S, Avale ME, Nakatani H, Pons S, Parnaudeau S, Tronche F, Vogt A, Monyer H, Vogel R, de Chaumont F, Olivo-Marin JC, Changeux JP, Maskos U, , A versatile system for the neuronal subtype specific expression of lentiviral vectors., FASEB J 2010 Mar; 24(3): 723-30.
• 2010
  Reperant C, Pons S, Dufour E, Rollema H, Gardier AM, Maskos U, , Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area., Neuropharmacology 2010 Feb; 58(2): 346-50.
• 2010
  Besson M, Belin D, McNamara R, Theobald DE, Castel A, Beckett VL, Crittenden BM, Newman AH, Everitt BJ, Robbins TW, Dalley JW, Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens, Neuropsychopharmacology 2010 Jan;35(2):560-9.
• 2009
  Arib O, Rat P, Molimard R, Chait A, Faure P, de Beaurepaire R, Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons, Eur. J. Pharmacol. 2010 Mar;629(1-3):47-52.
• 2009
  Lykhmus O, Koval L, Pavlovych S, Zouridakis M, Zisimopoulou P, Tzartos S, Tsetlin V, Volpina O, Cloëz-Tayarani I, Komisarenko S, Skok M, Functional effects of antibodies against non-neuronal nicotinic acetylcholine receptors, Immunol. Lett. 2010 Jan;128(1):68-73.
• 2009
  Wiklund A, Granon S, Faure P, Sundman E, Changeux JP, Eriksson LI, Object memory in young and aged mice after sevoflurane anaesthesia, Neuroreport 2009 Oct;20(16):1419-23.
• 2009
  Maouche K, Polette M, Jolly T, Medjber K, Cloëz-Tayarani I, Changeux JP, Burlet H, Terryn C, Coraux C, Zahm JM, Birembaut P, Tournier JM, {alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation, Am. J. Pathol. 2009 Nov;175(5):1868-82.
• 2009
  Nosjean A, Roux P, Perret E, Bohl D, Cholinergic differentiation of neural progenitors in adult mouse motor facial nucleus, J. Neurotrauma 2009 Aug;26(8):1417-27.
• 2009
  Forget B, Coen KM, Le Foll B, Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration–comparison with CB(1) receptor blockade, Psychopharmacology (Berl.) 2009 Sep;205(4):613-24.
• 2009
  Forget B, Hamon M, Thiébot MH, Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats, Psychopharmacology (Berl.) 2009 Aug;205(3):503-15.
• 2009
  Liu S, Bohl D, Blanchard S, Bacci J, Saïd G, Heard JM, Combination of microsurgery and gene therapy for spinal dorsal root injury repair, Mol. Ther. 2009 Jun;17(6):992-1002.
• 2008
  Grailhe R, Cardona A, Even N, Seif I, Changeux JP, Cloëz-Tayarani I, Regional changes in the cholinergic system in mice lacking monoamine oxidase A, Brain Res. Bull. 2009 Mar;78(6):283-9.
• 2008
  Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, Changeux JP, Maskos U, Fratta W, , Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration., J. Neurosci. 2008 Nov; 28(47): 12318-27.
• 2008
  Maubourguet N, Lesne A, Changeux JP, Maskos U, Faure P, , Behavioral sequence analysis reveals a novel role for beta2* nicotinic receptors in exploration., PLoS Comput Biol 2008 Nov; 4(11): e1000229.
• 2008
  Wiklund A, Granon S, Cloëz-Tayarani I, Faure P, le Sourd AM, Sundman E, Changeux JP, Eriksson LI, Sevoflurane anesthesia alters exploratory and anxiety-like behavior in mice lacking the beta2 nicotinic acetylcholine receptor subunit, Anesthesiology 2008 Nov;109(5):790-8.
• 2008
  Scherma M, Fadda P, Le Foll B, Forget B, Fratta W, Goldberg SR, Tanda G, The endocannabinoid system: a new molecular target for the treatment of tobacco addiction, CNS Neurol Disord Drug Targets 2008 Nov;7(5):468-81.
• 2008
  Avale ME, Faure P, Pons S, Robledo P, Deltheil T, David DJ, Gardier AM, Maldonado R, Granon S, Changeux JP, Maskos U, , Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion., Proc Natl Acad Sci U S A 2008 Oct; 105(41): 15991-6.
• 2008
  Even N, Cardona A, Soudant M, Corringer PJ, Changeux JP, Cloëz-Tayarani I, Regional differential effects of chronic nicotine on brain alpha 4-containing and alpha 6-containing receptors, Neuroreport 2008 Oct;19(15):1545-50.
• 2008
  Suarez SV, Amadon A, Giacomini E, Wiklund A, Changeux JP, Le Bihan D, Granon S, Brain activation by short-term nicotine exposure in anesthetized wild-type and beta2-nicotinic receptors knockout mice: a BOLD fMRI study, Psychopharmacology (Berl.) 2009 Mar;202(4):599-610.
• 2008
  Sartelet H, Maouche K, Totobenazara JL, Petit J, Burlet H, Monteau M, Tournier JM, Birembaut P, Expression of nicotinic receptors in normal and tumoral pulmonary neuroendocrine cells (PNEC), Pathol. Res. Pract. 2008;204(12):891-8.
• 2008
  Bohl D, Liu S, Blanchard S, Hocquemiller M, Haase G, Heard JM, Directed evolution of motor neurons from genetically engineered neural precursors, Stem Cells 2008 Oct;26(10):2564-75.
• 2008
  Besson M, Suarez S, Cormier A, Changeux JP, Granon S, Chronic nicotine exposure has dissociable behavioural effects on control and beta2-/- mice, Behav. Genet. 2008 Sep;38(5):503-14.
• 2008
  Le Foll B, Forget B, Aubin HJ, Goldberg SR, Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies, Addict Biol 2008 Jun;13(2):239-52.
• 2008
  Maskos U, , The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology., Br. J. Pharmacol. 2008 Mar; 153 Suppl 1(): S438-45.
• 2008
  Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, Varoqueaux F, Ramanantsoa N, Gallego J, Ronnenberg A, Winter D, Frahm J, Fischer J, Bourgeron T, Ehrenreich H, Brose N, Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism, Proc. Natl. Acad. Sci. U.S.A. 2008 Feb;105(5):1710-5.
• 2007
  Marti F, Korn H, Faure P, Interplay between subthreshold potentials and gamma oscillations in Mauthner cells’ presynaptic inhibitory interneurons, Neuroscience 2008 Feb;151(4):983-94.
• 2007
  Zanardi A, Ferrari R, Leo G, Maskos U, Changeux JP, Zoli M, , Loss of high-affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment., FASEB J 2007 Dec; 21(14): 4028-37.
• 2007
  Agulhon C, Platel JC, Kolomiets B, Forster V, Picaud S, Brocard J, Faure P, Brulet P, Bioluminescent imaging of Ca2+ activity reveals spatiotemporal dynamics in glial networks of dark-adapted mouse retina, J. Physiol. (Lond.) 2007 Sep;583(Pt 3):945-58.
• 2007
  Rakowski RF, Artigas P, Palma F, Holmgren M, De Weer P, Gadsby DC, Sodium flux ratio in Na/K pump-channels opened by palytoxin., J Gen Physiol 2007 Jul; 130(1): 41-54.
• 2007
  Besson M, Granon S, Mameli-Engvall M, Cloëz-Tayarani I, Maubourguet N, Cormier A, Cazala P, David V, Changeux JP, Faure P, Long-term effects of chronic nicotine exposure on brain nicotinic receptors, Proc. Natl. Acad. Sci. U.S.A. 2007 May;104(19):8155-60.
• 2007
  Moser N, Mechawar N, Jones I, Gochberg-Sarver A, Orr-Urtreger A, Plomann M, Salas R, Molles B, Marubio L, Roth U, Maskos U, Winzer-Serhan U, Bourgeois JP, Le Sourd AM, De Biasi M, Schröder H, Lindstrom J, Maelicke A, Changeux JP, Wevers A, Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures, J. Neurochem. 2007 Jul;102(2):479-92.
• 2007
  Maskos U, , Emerging concepts: novel integration of in vivo approaches to localize the function of nicotinic receptors., J Neurochem 2007 Feb; 100(3): 596-602.
• 2007
  Ramaz F, Bossy E, Dubois A, Gigan S, Forget B, Gross M, Boccara AC, Optical imaging in biological tissue: taking advantage of the light coherence properties, Conf Proc IEEE Eng Med Biol Soc 2007;2007:520.
• 2006
  Roszko I, Faure P, Mathis L, Stem cell growth becomes predominant while neural plate progenitor pool decreases during spinal cord elongation, Dev. Biol. 2007 Apr;304(1):232-45.
• 2006
  Cressant A, Besson M, Suarez S, Cormier A, Granon S, Spatial learning in Long-Evans Hooded rats and C57BL/6J mice: different strategies for different performance, Behav. Brain Res. 2007 Feb;177(1):22-9.
• 2006
  Cloëz-Tayarani I, Changeux JP, Nicotine and serotonin in immune regulation and inflammatory processes: a perspective, J. Leukoc. Biol. 2007 Mar;81(3):599-606.
• 2006
  Vincent P, Maskos U, Charvet I, Bourgeais L, Stoppini L, Leresche N, Changeux JP, Lambert R, Meda P, Paupardin-Tritsch D, , Live imaging of neural structure and function by fibred fluorescence microscopy., EMBO Rep 2006 Nov; 7(11): 1154-61.
• 2006
  Forget B, Barthélémy S, Saurini F, Hamon M, Thiébot MH, Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats, Psychopharmacology (Berl.) 2006 Nov;189(1):59-69.
• 2006
  Lamprianou S, Vacaresse N, Suzuki Y, Meziane H, Buxbaum JD, Schlessinger J, Harroch S, Receptor protein tyrosine phosphatase gamma is a marker for pyramidal cells and sensory neurons in the nervous system and is not necessary for normal development, Mol. Cell. Biol. 2006 Jul;26(13):5106-19.
• 2006
  Jacquier A, Buhler E, Schäfer MK, Bohl D, Blanchard S, Beclin C, Haase G, Alsin/Rac1 signaling controls survival and growth of spinal motoneurons, Ann. Neurol. 2006 Jul;60(1):105-17.
• 2006
  Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP, Faure P, , Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors., Neuron 2006 Jun; 50(6): 911-21.
• 2006
  Besson M, David V, Suarez S, Cormier A, Cazala P, Changeux JP, Granon S, Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome, Psychopharmacology (Berl.) 2006 Aug;187(2):189-99.
• 2006
  David V, Besson M, Changeux JP, Granon S, Cazala P, Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors, Neuropharmacology 2006 Jun;50(8):1030-40.
• 2006
  Bréjot T, Blanchard S, Hocquemiller M, Haase G, Liu S, Nosjean A, Heard JM, Bohl D, Forced expression of the motor neuron determinant HB9 in neural stem cells affects neurogenesis, Exp. Neurol. 2006 Mar;198(1):167-82.
• 2006
  Lamprianou S, Harroch S, Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system, J. Mol. Neurosci. 2006;29(3):241-55.
• 2006
  Molles BE, Maskos U, Pons S, Besson M, Guiard P, Guilloux JP, Evrard A, Cormier A, Mameli-Engvall M, Cloëz-Tayarani I, Nakatani H, Dufour N, Bemelmans AP, Mallet J, Cazala P, Gardier AM, David V, Faure P, Granon S, Changeux JP, , Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectors., J. Mol. Neurosci. 2006 ; 30(1-2): 105-6.
• 2006
  Tournier JM, Maouche K, Coraux C, Zahm JM, Cloëz-Tayarani I, Nawrocki-Raby B, Bonnomet A, Burlet H, Lebargy F, Polette M, Birembaut P, alpha3alpha5beta2-Nicotinic acetylcholine receptor contributes to the wound repair of the respiratory epithelium by modulating intracellular calcium in migrating cells, Am. J. Pathol. 2006 Jan;168(1):55-68.
• 2006
  Molles BE, Maskos U, Pons S, Besson M, Guiard P, Guilloux JP, Evrard A, Cormier A, Mameli-Engvall M, Cloëz-Tayarani I, Nakatani H, Dufour N, Bemelmans AP, Mallet J, Cazala P, Gardier AM, David V, Faure P, Granon S, Changeux JP, , Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectors., J. Mol. Neurosci. 2006 ; 30(1-2): 105-6.
• 2005
  Carro E, Trejo JL, Spuch C, Bohl D, Heard JM, Torres-Aleman I, Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer’s-like neuropathology in rodents: new cues into the human disease?, Neurobiol. Aging 2006 Nov;27(11):1618-31.
• 2005
  Forget B, Hamon M, Thiébot MH, Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats, Psychopharmacology (Berl.) 2005 Oct;181(4):722-34.
• 2005
  Mrsic-Flogel TD, Hofer SB, Creutzfeldt C, Cloëz-Tayarani I, Changeux JP, Bonhoeffer T, Hübener M, Altered map of visual space in the superior colliculus of mice lacking early retinal waves, J. Neurosci. 2005 Jul;25(29):6921-8.
• 2005
  Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, David V, Faure P, Granon S, Changeux JP, , Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors., Nature 2005 Jul; 436(7047): 103-7.
• 2005
  Raphael Etournay, Aziz El-Amraoui, Amel Bahloul, Stéphane Blanchard, Isabelle Roux, Guillaume Pézeron, Nicolas Michalski, Laurent Daviet, Jean-Pierre Hardelin, Pierre Legrain, Christine Petit, PHR1, an integral membrane protein of the inner ear sensory cells, directly interacts with myosin 1c and myosin VIIa., Journal of Cell Science, 2005, 118 (13), pp.2891-99. ⟨10.1242/jcs.02424⟩.
• 2005
  Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, Changeux JP, Corringer PJ, Nicotine upregulates its own receptors through enhanced intracellular maturation, Neuron 2005 May;46(4):595-607.
• 2005
  Leibovici M, Verpy E, Goodyear RJ, Zwaenepoel I, Blanchard S, Lainé S, Richardson GP, Petit C, Initial characterization of kinocilin, a protein of the hair cell kinocilium, Hear. Res. 2005 May;203(1-2):144-53.
• 2005
  Besson M, Martin JR, Centrophobism/thigmotaxis, a new role for the mushroom bodies in Drosophila, J. Neurobiol. 2005 Feb;62(3):386-96.
• 2004
  Cloëz-Tayarani I, Kayyali US, Fanburg BL, Cavaillon JM, 5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors, Life Sci. 2004 Dec;76(4):429-43.
• 2004
  Cordero-Erausquin M, Pons S, Faure P, Changeux JP, Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord, Pain 2004 Jun;109(3):308-18.
• 2004
  Sallette J, Bohler S, Benoit P, Soudant M, Pons S, Le Novère N, Changeux JP, Corringer PJ, An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine, J. Biol. Chem. 2004 Apr;279(18):18767-75.
• 2004
  Grailhe R, de Carvalho LP, Paas Y, Le Poupon C, Soudant M, Bregestovski P, Changeux JP, Corringer PJ, Distinct subcellular targeting of fluorescent nicotinic alpha 3 beta 4 and serotoninergic 5-HT3A receptors in hippocampal neurons, Eur. J. Neurosci. 2004 Feb;19(4):855-62.
• 2003
  Maskos U, McKay RD, Neural cells without functional N-Methyl-D-Aspartate (NMDA) receptors contribute extensively to normal postnatal brain development in efficiently generated chimaeric NMDA R1 -/- +/+ mice, Dev. Biol. 2003 Oct;262(1):119-36.
• 2003
  Philomena Mburu, Mirna Mustapha, Anabel Varela, Dominique Weil, Aziz El-Amraoui, Ralph H Holme, Andreas Rump, Rachel E Hardisty, Stéphane Blanchard, Roney S Coimbra, Isabelle Perfettini, Nick Parkinson, Ann-Marie Mallon, Pete Glenister, Mike J Rogers, Adam J Paige, Lee Moir, Jo Clay, Andre Rosenthal, Xue Zhong Liu, Gonzalo Blanco, Karen P Steel, Christine Petit, Steve D M Brown, Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31, Nature Genetics, 2003, 34, pp.421-428. ⟨10.1038/ng1208⟩.
• 2003
  Cloëz-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM, Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors, Int. Immunol. 2003 Feb;15(2):233-40.
• 2002
  Boëda B, El-Amraoui A, Bahloul A, Goodyear R, Daviet L, Blanchard S, Perfettini I, Fath KR, Shorte S, Reiners J, Houdusse A, Legrain P, Wolfrum U, Richardson G, Petit C, , Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle., EMBO J 2002 Dec; 21(24): 6689-99.
• 2002
  Samakoglu S, Bohl D, Heard JM, Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles, Mol. Ther. 2002 Dec;6(6):793-803.
• 2002
  Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D, Marmé F, Chérel Y, Salvetti A, Hurtrel B, Heard JM, Rivière Y, Moullier P, Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus, J. Virol. 2002 Nov;76(22):11605-11.
• 2002
  Marchand S, Devillers-Thiéry A, Pons S, Changeux JP, Cartaud J, Rapsyn escorts the nicotinic acetylcholine receptor along the exocytic pathway via association with lipid rafts, J. Neurosci. 2002 Oct;22(20):8891-901.
• 2002
  Maskos U, Kissa K, St Cloment C, Brûlet P, , Retrograde trans-synaptic transfer of green fluorescent protein allows the genetic mapping of neuronal circuits in transgenic mice., Proc Natl Acad Sci U S A 2002 Jul; 99(15): 10120-5.
• 2002
  Coimbra RS, Weil D, Brottier P, Blanchard S, Levi M, Hardelin JP, Weissenbach J, Petit C, A subtracted cDNA library from the zebrafish (Danio rerio) embryonic inner ear, Genome Res. 2002 Jun;12(6):1007-11.
• 2002
  El-Amraoui A, Schonn JS, Küssel-Andermann P, Blanchard S, Desnos C, Henry JP, Wolfrum U, Darchen F, Petit C, , MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes., EMBO Rep 2002 May; 3(5): 463-70.
• 2001
  Maskos U, Brüstle O, McKay RD, Long-term survival, migration, and differentiation of neural cells without functional NMDA receptors in vivo, Dev. Biol. 2001 Mar;231(1):103-12.
• 2001
  Cavaillon JM, Adib-Conquy M, Cloëz-Tayarani I, Fitting C, Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review, J. Endotoxin Res. 2001;7(2):85-93.
• 2001
  Palma F, Roncagliolo P, Bacigalupo J, Palacios AG, Membrane current of retinal rods of Caudiverbera caudiverbera (Amphibia: Leptodactylidae): dark noise, spectral and absolute light sensitivity., Vis Neurosci 2001 ; 18(4): 663-73.
• 1999
  Sarhan H, Cloëz-Tayarani I, Massot O, Fillion MP, Fillion G, 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes, Naunyn Schmiedebergs Arch. Pharmacol. 1999 Jan;359(1):40-7.
• 1998
  Massot O, Rousselle JC, Grimaldi B, Cloëz-Tayarani I, Fillion MP, Plantefol M, Bonnin A, Prudhomme N, Fillion G, Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype, Ann. N. Y. Acad. Sci. 1998 Dec;861:174-82.
• 1998
  Cloëz-Tayarani I, Cardona A, Sarhan H, Rousselle JC, Massot O, Edelman L, Fillion G, Mapping of 5-HT-moduline binding sites in guinea-pig brain by film and digital autoradiography, Brain Res. 1998 Jul;798(1-2):311-5.
• 1997
  Cloëz-Tayarani I, Cardona A, Rousselle JC, Massot O, Edelman L, Fillion G, Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors, Proc. Natl. Acad. Sci. U.S.A. 1997 Sep;94(18):9899-904.
• 1997
  Cloëz-Tayarani I, Fillion G, The in situ hybridization and immunocytochemistry techniques for characterization of cells expressing specific mRNAs in paraffin-embedded brains, Brain Res. Brain Res. Protoc. 1997 May;1(2):195-202.
• 1996
  Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloëz-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G, 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors, Mol. Pharmacol. 1996 Oct;50(4):752-62.
• 1996
  Cloëz-Tayarani I, Wusher N, Huerre M, Fillion G, Cellular localization of 5-HT1B receptor mRNA in the rat olfactory tubercle: do GABAergic neurons express the 5-HT1B gene?, Brain Res. Mol. Brain Res. 1996 Mar;36(2):337-42.
• 1995
  Bolanos-Jimenez F, Manhaes de Castro RM, Seguin L, Cloez-Tayarani I, Monneret V, Drieu K, Fillion G, Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain, Eur. J. Pharmacol. 1995 Dec;294(2-3):531-40.
• 1995
  Grimaldi B, Cloez-Tayarani I, Fillion MP, Mazie JC, Hen R, Fillion G, Production and characterization of an antibody directed against the mouse 5HT1B receptor, Neurosci. Res. 1995 Dec;24(1):97-101.
• 1995
  Brüstle O, Maskos U, McKay RD, Host-guided migration allows targeted introduction of neurons into the embryonic brain, Neuron 1995 Dec;15(6):1275-85.
• 1994
  Southern EM, Maskos U, Parallel synthesis and analysis of large numbers of related chemical compounds: applications to oligonucleotides, J. Biotechnol. 1994 Jun;35(2-3):217-27.
• 1993
  Maskos U, Southern EM, A study of oligonucleotide reassociation using large arrays of oligonucleotides synthesised on a glass support, Nucleic Acids Res. 1993 Oct;21(20):4663-9.
• 1993
  Maskos U, Southern EM, A novel method for the analysis of multiple sequence variants by hybridisation to oligonucleotides, Nucleic Acids Res. 1993 May;21(9):2267-8.
• 1993
  Maskos U, Southern EM, A novel method for the parallel analysis of multiple mutations in multiple samples, Nucleic Acids Res. 1993 May;21(9):2269-70.
• 1993
  Cloëz-Tayarani I, Fillion G, [Fundamental aspects of molecular biology. The multigene family of 5-HT1 receptors], Encephale 1993 May-Jun;19(3):215-9.
• 1993
  Simon-Chazottes D, Cloez-Tayarani I, Fillion MP, Guénet JL, Fillion G, The serotonin 5-HT1B receptor subtype (Htr1b) gene maps to mouse chromosome 9, Mamm. Genome 1993;4(7):397-8.
• 1992
  Southern EM, Maskos U, Elder JK, Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides: evaluation using experimental models, Genomics 1992 Aug;13(4):1008-17.
• 1992
  Maskos U, Southern EM, Parallel analysis of oligodeoxyribonucleotide (oligonucleotide) interactions. I. Analysis of factors influencing oligonucleotide duplex formation, Nucleic Acids Res. 1992 Apr;20(7):1675-8.
• 1992
  Maskos U, Southern EM, Oligonucleotide hybridizations on glass supports: a novel linker for oligonucleotide synthesis and hybridization properties of oligonucleotides synthesised in situ, Nucleic Acids Res. 1992 Apr;20(7):1679-84.
• 1992
  Weydert A, Cloez-Tayarani I, Fillion MP, Simon-Chazottes D, Guenet JL, Fillion G, Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig, C. R. Acad. Sci. III, Sci. Vie 1992;314(10):429-35.
• 1992
  Cloëz-Tayarani I, Harel-Dupas C, Fillion G, Inhibition of [3H] gamma-aminobutyric acid release from guinea-pig hippocampal synaptosomes by serotonergic agents, Fundam Clin Pharmacol 1992;6(8-9):333-41.
• 1991
  Harel-Dupas C, Cloëz I, Fillion G, , Antagonism by antidepressant drugs of the inhibitory effect of trifluoromethylphenylpiperazine (TFMPP) on [3H]acetylcholine release in rat or guinea-pig hippocampal synaptosomes., Eur Neuropsychopharmacol 1991 May; 1(2): 157-64.
• 1991
  Harel-Dupas C, Cloëz I, Fillion G, , The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes., J Neurochem 1991 Jan; 56(1): 221-7.
• 1991
  Fillion G, Barone P, Cloëz I, Fillion MP, Harel C, Massot O, Rousselle JC, Zifa E, , A cerebral endogenous factor regulates the activity of the serotonergic receptors modulating the neuronal release of acetylcholine., Adv Exp Med Biol 1991 ; 287(): 165-76.
• 1989
  Tayarani I, Cloëz I, Lefauconnier JM, Bourre JM, , Sodium-dependent high-affinity uptake of taurine by isolated rat brain capillaries., Biochim Biophys Acta 1989 Oct; 985(2): 168-72.
• 1989
  Tayarani I, Cloëz I, Clément M, Bourre JM, , Antioxidant enzymes and related trace elements in aging brain capillaries and choroid plexus., J Neurochem 1989 Sep; 53(3): 817-24.
• 1989
  Cloëz I, Tayarani I, Morel F, Bourre JM, , Alterations in protective enzymes against peroxidation in the central and peripheral nervous system of control and dysmyelinating mutant mice., J Neurochem 1989 May; 52(5): 1353-8.
• 1987
  Cloëz I, Bourre JM, , Copper, manganese and zinc in the developing brain of control and quaking mice., Neurosci Lett 1987 Dec; 83(1-2): 118-22.
• 1987
  Cloëz I, Dumont O, Piciotti M, Bourre JM, , Alterations of lipid synthesis in the normal and dysmyelinating trembler mouse sciatic nerve by heavy metals (Hg, Pb, Mn, Cu, Ni)., Toxicology 1987 Oct; 46(1): 65-71.
• 1987
  Bourre JM, Cloez I, Galliot M, Buisine A, Dumont O, Piciotti M, Prouillet F, Bourdon R, , Occurrence of manganese, copper and zinc in myelin. Alterations in the peripheral nervous system of dysmyelinating trembler mutant are at variance with brain mutants (quaking and shiverer)., Neurochem Int 1987 ; 10(3): 281-6.